Macquarie Remains a Buy on Takeda Pharmaceutical Co (TKPHF)
In a report released today, from Macquarie maintained a Buy rating on Takeda Pharmaceutical Co, with a price target of Yen5,000.00. The company’s shares closed last Friday at $27.33.Elevate Your Investing...
Bernstein Reaffirms Their Hold Rating on Takeda Pharmaceutical Co (TKPHF)
Bernstein analyst Miki Sogi maintained a Hold rating on Takeda Pharmaceutical Co today and set a price target of Yen4,500.00. The company’s shares closed yesterday at $27.17.Elevate Your Investing Strategy:...
Why Shares of Phathom Pharmaceutical Jumped This Week
Investors are reading between the lines to see if the company is fixing its problems regarding its lead therapy.
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
SINGAPORE, Dec 6, 2022 - (ACN Newswire) - Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National...